This curve and the corresponding AUC show that the combination of the three cytokines (TGF-β1, Dkk1, and IL-17A) as biomarkers have the predictive capacity to discriminate those patients with more severe arthritis evolution and, therefore, who will require the use of more forceful, but also more costly, therapeutic measures. Here, TGFB1 is linked to arthritic joint disease.